Contact Us
Home Jazz Pharmaceuticals Announces Third Quarter 2011 Results Conference Call on November 1

News Release

Media Contact

Kristin Bhavnani
Head of Global Corporate Communications
Jazz Pharmaceuticals plc

Send Email
Ireland: +353 1 637 2141
US: 215-867-4948

Jazz Pharmaceuticals Announces Third Quarter 2011 Results Conference Call on November 1

October 20, 2011
PDF Version

PALO ALTO, Calif., Oct. 20, 2011 /PRNewswire via COMTEX/ -- PALO ALTO, Calif., Oct. 20, 2011 -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) today announced that it will host a conference call and live webcast on Tuesday, November 1, 2011 at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time. During the call, company management will provide a business and financial update and review third quarter 2011 results.

The live webcast and press release may be accessed from the Investors section of the Jazz Pharmaceuticals' website at http://www.jazzpharmaceuticals.com/. Please connect to the website prior to the start of the conference call to ensure adequate time for any software downloads that may be necessary to listen to the webcast. An archived version of the webcast will be available for at least one week.

Investors may participate in the conference call by dialing 1-866-700-7173 in the U.S., or 1-617-213-8838 outside the U.S., and entering passcode 78394935.

About Jazz Pharmaceuticals, Inc.

Jazz Pharmaceuticals (Nasdaq: JAZZ) is a specialty pharmaceutical company focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry. For further information see http://www.jazzpharmaceuticals.com/.

SOURCE Jazz Pharmaceuticals, Inc.